{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:13:26Z","timestamp":1791886406196,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T00:00:00Z","timestamp":1473120000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1816-4","type":"journal-article","created":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T06:14:34Z","timestamp":1473142474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Determinants of treatment-related paradoxical reactions during anti-tuberculosis therapy: a case control study"],"prefix":"10.1186","volume":"16","author":[{"given":"Colin Stewart","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette Joanne","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan Angus MacCormick","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence Peter","family":"Ormerod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Fisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather June","family":"Milburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas Martin","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham Henry","family":"Bothamley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7501-4448","authenticated-orcid":false,"given":"Marc Caeroos Isaac","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,6]]},"reference":[{"issue":"8","key":"1816_CR1","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/thx.2003.019224","volume":"59","author":"R Breen","year":"2004","unstructured":"Breen R, Smith C, Bettinson H, Dart S, Bannister B, Johnson M, Lipman M. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax. 2004;59(8):704\u20137.","journal-title":"Thorax"},{"issue":"1","key":"1816_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/01.qco.0000200543.80712.01","volume":"19","author":"M Lipman","year":"2006","unstructured":"Lipman M, Breen R. Immune reconstitution inflammatory syndrome in HIV. Curr Opin Infect Dis. 2006;19(1):20\u20135.","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"1816_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1164\/ajrccm.158.1.9712001","volume":"158","author":"M Narita","year":"1998","unstructured":"Narita M, Ashkin D, Hollender E, Pitchenik A. Paradoxical worsening of tuberculosis following antiretroviral therapy inpatients with AIDS. Am J Respir Crit Care Med. 1998;158(1):157\u201361.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1816_CR4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ccm.2009.08.013","volume":"30","author":"G Meintjes","year":"2009","unstructured":"Meintjes G, Rabie H, Wilkinson RJ, Cotton MF. Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy. Clin Chest Med. 2009;30(4):797\u2013810.","journal-title":"Clin Chest Med"},{"key":"1816_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijid.2014.12.030","volume":"32","author":"LC Bell","year":"2015","unstructured":"Bell LC, Breen R, Miller RF, Noursadeghi M, Lipman M. Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. Int J Infect Dis. 2015;32:39\u201345.","journal-title":"Int J Infect Dis"},{"key":"1816_CR6","doi-asserted-by":"publisher","unstructured":"Coussens AK, Wilkinson RJ, Nikolayevskyy V, et al. Ethnic variation in inflammatory profile in tuberculosis. PLoS Pathog. 9(7): e1003468. doi: 10.1371\/journal.ppat.1003468 .","DOI":"10.1371\/journal.ppat.1003468"},{"key":"1816_CR7","doi-asserted-by":"crossref","unstructured":"Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WC, van der Ven AJ, Dekhuijzen R. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J Gastroenterol Hepatol. 2008;23(2):192\u2013202.","DOI":"10.1111\/j.1440-1746.2007.05207.x"},{"issue":"4","key":"1816_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1473-3099(15)70008-3","volume":"15","author":"S Ravimohan","year":"2015","unstructured":"Ravimohan S, Tamuhla N, Steenhoff AP, et al. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study. Lancet Infect Dis. 2015;15(4):429\u201338.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"1816_CR9","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1097\/QAD.0000000000000311","volume":"28","author":"LA Chakrabarti","year":"2014","unstructured":"Chakrabarti LA, Boucherie C, Bugault F, et al. Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS. 2014;28(11):1593\u2013602.","journal-title":"AIDS"},{"key":"1816_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5897\/JAHR2015.0327","volume":"7","author":"NF Walker","year":"2015","unstructured":"Walker NF, Scriven J, Meintjes G, Wilkinson RJ. Immune reconstitution inflammatory syndrome in HIV-infected patients. HIV AIDS. 2015;7:49\u201364.","journal-title":"HIV AIDS"},{"issue":"12","key":"1816_CR11","first-page":"1290","volume":"11","author":"SL Cheng","year":"2007","unstructured":"Cheng SL, Wang HC, Yang PC. Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2007;11(12):1290\u20135.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"1816_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10096-003-0998-z","volume":"22","author":"VC Cheng","year":"2003","unstructured":"Cheng VC, Yam WC, Woo PC, Lau SK, Hung IF, Wong SP, Cheung WC, Yuen KY. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis. 2003;22(10):597\u2013602.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"1816_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1620\/tjem.223.199","volume":"223","author":"JW Jung","year":"2011","unstructured":"Jung JW, Shin JW, Kim JY, Park IW, Choi BW, Seo JS, Choi JC. Risk factors for development of paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pleural tuberculosis. Tohoku J Exp Med. 2011;223(3):199\u2013204.","journal-title":"Tohoku J Exp Med"},{"issue":"6","key":"1816_CR14","doi-asserted-by":"crossref","first-page":"846","DOI":"10.5588\/ijtld.11.0642","volume":"16","author":"K Jeon","year":"2012","unstructured":"Jeon K, Choi WI, An JS, et al. Paradoxical response in HIV-negative patients with pleural tuberculosis: a retrospective multicentre study. Int J Tuberc Lung Dis. 2012;16(6):846\u201351.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1816_CR15","doi-asserted-by":"crossref","unstructured":"Brown CS, Breen R, Smith C, Bothamley G, Price N, Lilburn H, Lipman M. Ethnic determinants of paradoxical reaction during antituberculosis therapy. Poster Presentation A1685. New York: American Thoracic Society; 2009.","DOI":"10.1164\/ajrccm-conference.2009.179.1_MeetingAbstracts.A1685"},{"issue":"7624","key":"1816_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E Elm von","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806\u20138.","journal-title":"BMJ"},{"key":"1816_CR17","unstructured":"Office for National Statistics. Ethnic Group. Webpage - http:\/\/ons.gov.uk\/ons\/guide-method\/measuring-equality\/equality\/ethnic-nat-identity-religion\/ethnic-group\/index.html . Accessed 05 Nov 2015."},{"issue":"18","key":"1816_CR18","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1097\/QAD.0b013e32833ef5d7","volume":"42","author":"D Lowe","year":"2010","unstructured":"Lowe D. The ESR, in HIV: A Neglected Parameter? AIDS. 2010;42(18):2773\u20135.","journal-title":"AIDS"},{"key":"1816_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","volume":"10","author":"M Muller","year":"2010","unstructured":"Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:251\u201361.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"1816_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jinf.2010.08.011","volume":"61","author":"KH Park","year":"2010","unstructured":"Park KH, Cho OH, Chong YP, et al. Post-therapy paradoxical response in immunocompetent patients with lymph node tuberculosis. J Infect. 2010;61(5):430\u20134.","journal-title":"J Infect"},{"key":"1816_CR21","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1001\/archinte.168.9.936","volume":"168","author":"RJ Asghar","year":"2008","unstructured":"Asghar RJ, Pratt RH, Kammerer JS, Navin TR. Tuberculosis in South Asians living in the United States, 1993\u20132004. Arch Intern Med. 2008;168:936\u201342.","journal-title":"Arch Intern Med"},{"issue":"6","key":"1816_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S1413-8670(11)70250-1","volume":"15","author":"D De","year":"2011","unstructured":"De D, Nath Sarkar R, Phaujdar S, Bhattacharyya K, Krishna PH. Incidence and risk factors of immune reconstitution inflammatory syndrome in HIV-TB coinfected patients. Braz J Infect Dis. 2011;15(6):553\u20139.","journal-title":"Braz J Infect Dis"},{"key":"1816_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0954-6111(06)80142-3","volume":"86","author":"British Thoracic Society Research Committee","year":"1992","unstructured":"British Thoracic Society Research Committee. Six-months versus nine-months chemotherapy for tuberculosis of lymph nodes: preliminary results. Respir Med. 1992;86:15\u20139.","journal-title":"Respir Med"},{"key":"1816_CR24","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0954-6111(05)80265-3","volume":"87","author":"IA Campbell","year":"1993","unstructured":"Campbell IA, Ormerod LP, Friend JAR, Jenkins PA, Prescott RJ. Six-months versus nine-months chemotherapy for tuberculosis of lymph nodes: final results. Respir Med. 1993;87:621\u20133.","journal-title":"Respir Med"},{"key":"1816_CR25","doi-asserted-by":"crossref","unstructured":"Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008 Aug;8(8):516\u201323.","DOI":"10.1016\/S1473-3099(08)70184-1"},{"issue":"3","key":"1816_CR26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/cid\/cis899","volume":"56","author":"S Marais","year":"2013","unstructured":"Marais S, Meintjes G, Pepper DJ, et al. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis. 2013;56(3):450\u201360.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1816_CR27","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1071\/SH14093","volume":"11","author":"HY Tan","year":"2014","unstructured":"Tan HY, Yong YK, Lim SH, et al. Tuberculosis (TB)-associated immune reconstitution inflammatory syndrome in TB-HIV co-infected patients in Malaysia: prevalence, risk factors, and treatment outcomes. Sex Health. 2014;11(6):532\u20139.","journal-title":"Sex Health"},{"key":"1816_CR28","first-page":"670347","volume":"2012","author":"IA Alawin","year":"2012","unstructured":"Alawin IA, Karnath BM. Paradoxical Immune Reconstitution Syndrome Presenting as Acute Respiratory Distress Syndrome in a Leukemia Patient during Neutrophil Recovery. Case Rep Hematol. 2012;2012:670347.","journal-title":"Case Rep Hematol"},{"issue":"9","key":"1816_CR29","first-page":"1057","volume":"9","author":"R Belknap","year":"2005","unstructured":"Belknap R, Reves R, Burman W. Immune reconstitution to Mycobacterium tuberculosis after discontinuing infliximab. Int J Tuberc Lung Dis. 2005;9(9):1057\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1816_CR30","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/QAD.0b013e3283477d67","volume":"25","author":"LJ Haddow","year":"2011","unstructured":"Haddow LJ, Dibben O, Moosa MY, Borrow P, Easterbrook PJ. Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS. 2011;25:1163\u201374.","journal-title":"AIDS"},{"issue":"5","key":"1816_CR31","doi-asserted-by":"publisher","first-page":"e63541","DOI":"10.1371\/journal.pone.0063541","volume":"8","author":"G Narendran","year":"2013","unstructured":"Narendran G, Andrade BB, Porter BO, et al. Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) in HIV Patients with Culture Confirmed Pulmonary Tuberculosis in India and the Potential Role of IL-6 in Prediction. PLoS One. 2013;8(5):e63541.","journal-title":"PLoS One"},{"key":"1816_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/pmj.77.905.185","volume":"77","author":"BC Jha","year":"2001","unstructured":"Jha BC, Dass A, Gupta R, Singhal S. Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management. Postgrad Med J. 2001;77:185\u20137.","journal-title":"Postgrad Med J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1816-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1816-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1816-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T02:41:29Z","timestamp":1568342489000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1816-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1816"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1816-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,6]]},"article-number":"479"}}